Neuropace Inc. Form 8-K Summary
Business Context and Reporting Period
Neuropace, Inc. (NPCE), a Delaware corporation, filed this Current Report on Form 8-K on January 15, 2025. The company is an emerging growth company with its principal executive offices in Mountain View, California. This filing serves as a Regulation FD disclosure regarding an upcoming investor presentation.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of an event and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
Neuropace is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, at approximately 4:30 p.m. Pacific time (7:30 p.m. Eastern time). The presentation will be available via a live audio webcast. Presentation materials will be posted on the Events section of the NeuroPace investor website. The company notes that this information is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- Verify the live webcast access instructions on the NeuroPace investor relations website.
- Confirm the presentation materials are available on the company's Events page.
- Note that this 8-K contains no financial data; investors should refer to the company's most recent 10-K or 10-Q for financial metrics.
- Recognize the company's status as an emerging growth company.